Raaj Medisafe India Limited (BOM:524502)
India · Delayed Price · Currency is INR 99.85
0.00 (0.00%)
At close: Sep 11, 2026
Raaj Medisafe India Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 936.47 | 800.15 | 624.2 | 432.49 | 386.23 | 346.94 |
| 936.47 | 800.15 | 624.2 | 432.49 | 386.23 | 346.94 | |
Revenue Growth | 39.06% | 28.19% | 44.33% | 11.98% | 11.32% | 9.08% |
Cost of Revenue | 617.95 | 514.76 | 437.82 | 295.26 | 270.56 | 266.87 |
Gross Profit | 318.52 | 285.39 | 186.39 | 137.23 | 115.67 | 80.07 |
Selling, General & Admin | 56.23 | 51.83 | 40.27 | 33.2 | 27.72 | 29.06 |
Other Operating Expenses | 130.3 | 115.91 | 59.8 | 37.67 | 31.83 | 0.1 |
Operating Expenses | 209.15 | 188.16 | 114.55 | 79.25 | 67.07 | 36.4 |
Operating Income | 109.37 | 97.22 | 71.84 | 57.98 | 48.6 | 43.67 |
Interest Expense | -41.46 | -36.42 | -20.18 | -14.56 | -10.59 | -6.62 |
Interest & Investment Income | - | 5.23 | 1.75 | 0.5 | 0.11 | 0.21 |
Currency Exchange Gain (Loss) | - | - | - | 0.01 | 0.06 | 0 |
Other Non Operating Income (Expenses) | 7.12 | -2.82 | -0.86 | -1.04 | -0.46 | -0.51 |
EBT Excluding Unusual Items | 75.03 | 63.22 | 52.55 | 42.89 | 37.72 | 36.75 |
Other Unusual Items | - | - | - | - | -0.01 | 0.53 |
Pretax Income | 75.03 | 63.22 | 52.55 | 42.89 | 37.72 | 37.27 |
Income Tax Expense | 51.8 | 45.13 | -8.76 | 9.6 | 4.42 | 7.15 |
Net Income | 23.23 | 18.1 | 61.31 | 33.29 | 33.3 | 30.13 |
Net Income to Common | 23.23 | 18.1 | 61.31 | 33.29 | 33.3 | 30.13 |
Net Income Growth | -64.90% | -70.48% | 84.20% | -0.04% | 10.52% | 31.03% |
Shares Outstanding (Basic) | 17 | 16 | 13 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 17 | 16 | 13 | 11 | 11 | 11 |
Shares Change | 29.60% | 24.63% | 20.87% | - | 2.06% | -3.82% |
EPS (Basic) | 1.34 | 1.10 | 4.65 | 3.05 | 3.05 | 2.82 |
EPS (Diluted) | 1.34 | 1.10 | 4.60 | 3.05 | 3.05 | 2.82 |
EPS Growth | -72.92% | -76.09% | 50.69% | -0.04% | 8.29% | 36.23% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -298.32 | -147.96 | -73.64 | -15.52 | 12.35 |
Free Cash Flow Per Share | - | -18.16 | -11.23 | -6.75 | -1.42 | 1.16 |
Gross Margin | 34.01% | 35.67% | 29.86% | 31.73% | 29.95% | 23.08% |
Operating Margin | 11.68% | 12.15% | 11.51% | 13.41% | 12.58% | 12.59% |
Profit Margin | 2.48% | 2.26% | 9.82% | 7.70% | 8.62% | 8.68% |
Free Cash Flow Margin | - | -37.28% | -23.70% | -17.03% | -4.02% | 3.56% |
EBITDA | 131.26 | 117.64 | 86.32 | 66.35 | 56.12 | 50.91 |
EBITDA Margin | 14.02% | 14.70% | 13.83% | 15.34% | 14.53% | 14.67% |
D&A For EBITDA | 21.9 | 20.42 | 14.48 | 8.37 | 7.52 | 7.24 |
EBIT | 109.37 | 97.22 | 71.84 | 57.98 | 48.6 | 43.67 |
EBIT Margin | 11.68% | 12.15% | 11.51% | 13.41% | 12.58% | 12.59% |
Effective Tax Rate | 69.04% | 71.38% | - | 22.39% | 11.72% | 19.17% |
Revenue as Reported | 943.59 | 805.78 | 626.19 | 433.09 | 386.45 | 347.2 |
Advertising Expenses | - | 0.12 | 0.32 | 0.15 | 0.18 | 0.12 |